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Abstract 
The sequencing race has ended and the functional race has already begun. Microarray technology enables 
simultaneous gene expression analysis of thousands of genes, enabling a snapshot of an organisms’ 
transcriptome at an unprecedented resolution. The close correlation between gene transcription and 
function, allow the inference of biological processes from the assessed transcriptome profile. Among the 
sophisticated analytical problems in microarray technology at the front and back ends respectively, are the 
selection of optimal DNA oligos and computational analysis of the genes expression. In this review paper, 
we analyse important methods in use today in customized oligos design. In the course of executing this, 
we discovered that the oligos designer algorithm hanged on gene PFA0135w of chromosome 1, while 
designing oligos for the gene sequences of Plasmodium falciparum. We do not know the reason for this 
yet, as the algorithm runs on other sequences like the yeast (Saccharomyces cervisiae) and Neurospora 
crassa. We conclude the paper highlighting the procedures encompassing the back end phase and discuss 
their application to the development of vaccines and drugs for malaria treatment. Note that, malaria is the 
cause of significant global morbidity and mortality with 300-500 million cases annually. Our aims are not 
ends, but a means to achieve the following: Iterate the need for experimental biologists to (i) know how to 
design their customized oligos and (ii) have some idea about gene expression analysis and the need for 
cooperation between experimental biologists and their counterpart, the computational biologists. These 
will help experimental biologists to coordinate very well the front and the back ends of the system 
biology analysis of the whole genome effectively. 
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INTRODUCTION 
 
The expression "systems biology" is often 
used today to describe attempts at 
unraveling molecular systems (the function 
of the genome), beyond the traditional level 
of single genes and single proteins, focusing 
on the intricate circuitry that governs 
growth, development, homeostasis, 
behaviour and the onset of diseases, which is 
largely controlled by the RNA and proteins 
encoded by the cognate genes and the 
complex and dynamic interaction of the 
genes with the environment. A detailed 
conceptual view of gene regulatory circuitry 
in organisms will require extensive 
expression monitoring at the level of the 
whole genome. The challenge of this 
biological analysis requires the development 
and implementation of sophisticated 
analytical methods. DNA microarray 
technology offers a great tool for these 
tasks10. The basic steps to study the function 
of a whole genome using system biology 
include the following6: (i) identify all the 
players of the system, that is, all the 
components that are involved (e.g. genes, 
proteins, compartments), (ii) perturb each 
component through a series of genetic or 
environmental manipulations and record the 
global response using high-throughput 
technologies (e.g. microarrays), and (iii) 
build a global model and generate new 
testable hypotheses. Return to (ii) and in 
some cases to (i) when missing components 
are discovered. In microarray term, these 
steps are (i) design of the DNA chips 
(arrays), (ii) gene expression profiling 
experiments, and iii) computational analysis 
of the array data3. DNA chips are glass 
surfaces bearing thousands of DNA 
fragments at discrete sites at which the 
fragments are available for hybridization. 
Hybridization of fluorescently labelled RNA 
and DNA-derived samples to DNA chips 
allows the monitoring of gene expression or 
occurrence of polymorphisms in genomic 
DNA17. Two DNA chip formats currently in 
wide use are the cDNA array format and 
high density synthetic oligonucleotide array 
format. Oligonucleotide expression arrays 
include both short oligo (20-25 mers) arrays 
(Affymetrix geneChip) and long oligo (50-
70 mers) arrays. It has been noted in Le 
Roch et al.11 that longer oligos than 25-mer 
(that could be hybridization problematic) 
might be needed to generate accurate 
expression profiles. Nevertheless, 
Affymetrix has combined oligonucleotide 
synthesis and photolithographic computer 
chip synthesis to generate DNA chips that 
display 40 000-65 000 DNA short 
oligonucleotides which represent up to 9000 
genes on a 1.6 cm2 glass surface. Here, we 
focus on the design of the DNA chips (the 
high density synthetic oligonucleotide array 
format) and the computational analysis of 
the array data. 
 
MICROARRAY EXPERIMENT 
The following figure shows the basic 
procedures involved in the set up of a 
microarray experiment.  
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A microarray experiment based on an in-
laboratory custom built auxillaries is less 
expensive and made possible via many 
available free software and protocols. 
Microarrays can be made from either the 
spotted glass slide or the Affymetrix 
GeneChip. Affymetrix chips are high 
density array. The technology involved is 
highly standardized and are exclusively 
provided by Affymetrix. Hence the chips 
and the required equipments are expensive. 
Spotted glass slide microarrays made from 
microscope glass slide are significantly 
cheap and can be produced by any 
laboratory equipped with the necessary 
instruments for DNA production, 
purification, analysis and spotting. 
Functional information about the genes of an 
organism represented on the microarrays via 
oligonucleotides (oligos) are measured by 
their hybridization density with the probe. 
The probe here represents the RNA at all or 
some of its life cycle. 
 
In data analysis and interpretation, it is 
popular to   use the one-way ANOVA 
statistical test to identify differentially 
expressed genes from the time course data19 
and cluster analysis to classify genes to   be 
of similar functions based on their similar 
expression profiles4. A recent work of 
statistical analysis on gene expression can be 
found in Wichert et al18, while the genes 
network3,9 (also on the computational side), 
an alternative to cluster analysis, provides 
another strategy to elucidate gene functions.  
 
SELECTION OF OPTIMAL DNA OLIGOS 
FOR GENE EXPRESSION ARRAYS  
This was done at the target preparation step 
of a microarray experiment. How should the 
oligos be chosen? One thing is clear; each 
oligo should be specific for exactly one 
gene. This is because, in the experiment, 
only the fluorescently labelled transcripts of 
a single gene should hybridize to a given 
oligo, so the measurement taken at the 
oligos spot can be interpreted as the 
corresponding genes expression level in the 
sample. Note that the cDNA or mRNA from 
the sample need not contain the perfect 
Watson-Crick complement of an oligo to 
hybridize.  
 
Computationally, using the terminologies 
from Rahmann (2002)15, given  two 
sequences, the master sequence, the DNA 
sequence for which we wish to design oligos 
(usually some or the whole part of the 
coding region of a genome, in other words, a 
list of genes) and the background sequence 
(usually consists of all known genes and/or 
their reversed complements), the oligos 
design problem is to select patterns of size L 
(this is usually peck at 25, 50 , or 70) at 
more or less constant melting temperature 
(usually denoted as TM)  that are specific 
(unique) to each gene (note that more than 
one oligos may represent a gene), allowing 
very small percentage of similarity to the 
background sequence at m-mismatches.  
 
The melting temperature TM of an oligo-
cDNA duplex is the temperature at which 
half of the potential duplexes   have 
hybridized and are in the DNA-typical 
double-helical state, and the other half is still 
single-stranded. Note that, in principle, the 
melting temperature of perfect as well as 
approximate Watson-Crick paired oligos, 
can be computed assuming a simple nearest-
neighbour model16. Common additional 
parameters include the GC content of the 
oligo, its distance from the 3' end of the 
background sequence, and minimum 
distance between the 5' ends of two adjacent 
oligos, if two or more oligos are 
representing a gene. Furthermore, sequences 
that are internal self binding (form 
secondary structure), of low-complexity and 
contain 'GGGGG', 'CCCCC', 'TTTTT', or 
'AAAAA' are avoided in the oligos. For 
example, we used the algorithm of Bozdech 
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et al.3 to identify the oligos of length 70 (one 
per gene) with GC content equal 28 from the 
Plasmodium falciparum. Their results for 
falcipain 2, a gene involved in chloroquine 
resistance are as follows: 
 
falcipain 2 
PF11_0161 TTCTATGATAATAAAATGAAA
GATATAAATAAAAACAATAAC
AATAATACTTCATCCGATTTTA
AAGGTC 
PF11_0162 TGGTGGATATATAACTAATGC
TTTTGATGATATGATTGATCTT
GGAGGATTATGTTCTCAAGAT
GATTAT 
PF11_0163 TGGGTTGCCTTTTATCGTTCAA
ACAACTTCCCTGTTTGCAGATC
TTTCTCAGCTGAATATCATGGA
TTTG 
 
A straightforward  (but lazy) approach is to 
consider as candidate oligos, all possible L-
mers contained in the master sequence, 
filtering out all L-mers that are repeats. We 
have developed tool for this in Adebiyi et 
al1. Other filtering parameters can then 
follow as discussed above. Existing oligos 
selector algorithms include that of Kaderali 
and Schliep7, Li and Stormo13, Rouillard, 
Herbert and Zuker14 and Rahamann15. Other 
algorithms include Lockhart et al.10 and 
Bozdech et al.2. A computational analysis of 
the methods use to select oligos is important 
since the correctness of the front-end, of 
course has great influence on the results we 
will obtain at the middle and back ends 
respectively. Our computational analysis is 
built using suffix tree8 with the algorithms 
described by Gusfield5. 
 
Performing tasks to computationally analyze 
important methods in use today to design 
customized oligos, the algorithm of 
Rouillard et al.14 hanged on gene 
PFA0135w of chromosome 1, while 
designing oligos for publicly available 
genome of Plasmodim falciparum (see 
acknowledgement). Their algorithm does 
not behave this way when we used it on 
Yeast (Saccharomyces cervisiae) and 
Neurospora crassa genes. We further 
discovered that the results of the four 
algorithms (Li and Stormo13, Rouillard et 
al.14, Rahamann15 and Bozdech et al.2) 
tested, are at variance. This poses serious 
hindrance to the development of microarrays 
using the oligonucleotides approach. And 
since this approach has significant 
advantage over its alternative13, our finding 
thus calls for further work in this area. A 
further work on this problem and detail 
comparative analysis of existing methods 
are presently been undertaken by us. 
 
DEVELOPMENT OF VACCINES AND 
DRUGS FOR MALARIA TREATMENTS 
After the completion of the genome 
sequence for Plasmodium falciparum, Le 
Roch et al.12 carried out a large scale 
microarray experiment to determine the 
functions (of more than 95%) of the 
predicted Plasmodium falciparum genes as 
the parasite moves through its life cycle, 
using an Affymetrix chip containing 
260,596 25-nucleotide single-stranded 
probes from predicted coding sequence 
(5159 genes) that include mitochondrion and 
plasmid sequences.  
 
This study12 is important because the spread 
of malaria relies on finely tuned reciprocal 
interactions between Plasmodium 
falciparum and the Anopheles mosquito 
vector, which allow the parasite to complete 
its cycle without seriously affecting the 
vectors’ fitness. Therefore, a comprehensive 
understanding of the delicate interactions 
between Anopheles and Plasmodium can 
serve the development of malaria control 
strategies based on blocking the parasite’s 
development in the mosquito. Le Roch et 
al.12,13 examined nine different stages of the 
parasite development, namely mosquito 
salivary gland sporozoites, which infect 
humans; seven periodic erthrocytic asexual 
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stages and lastly, the sexual stage 
gametocyte, the form by which the parasite 
is transmitted from humans to mosquitoes. It 
was discovered that 4557 genes (88% of the 
predicted genes) were expressed in at least 
one stage of the life cycle. A total of 602 
genes were not expressed in any stage 
examined, and a majority (87%) of this code 
for hypothetical proteins that may be 
expressed at other stages of the life cycle. In 
a personal communication, Le Roch 
confirmed that few of these genes may be 
expressed at a background level, thus 
making them difficult to detect, but a guess 
is that most of them should be expressed 
during the liver stages or/and mosquitos gut 
stages. In a further analysis, Le Roch et al. 
(2003)12 discovered that out of the 4557 
genes that expressed themselves, 2235 genes 
were expressed at some stages, while the 
remaining 2322 genes were designated as 
constitutively expressed, since they are 
expressed at all examined stages. They 
noted that, this group contains genes coding 
for both uncharacterised hypothetical 
proteins and house keeping proteins and 
many of the hypothetical proteins are likely 
involved in maintenance of  the parasite 
function throughout the life cycle, and those 
without human orthologs might represent 
targets for drug development. Cluster 
analysis provided 15 cluster groups. The 
genes in each group are of similar 
expression profiles, thus assumed to be of 
similar function. Each group also contains 
genes, whose functions are known. The 
highest  probability obtained that any of 
these groups overlaped by chance with these 
known genes is 0.029. These clusters 
provided highly probable genes that  may 
represent targets for functional disruption of 
the liver stage invasion process (either by 
small molecule interactions or vaccination), 
transmission blocking interventions, drugs 
focusing on disruption of the parasite at its 
replicating stage, etc. Notably among their 
results is that, cluster 7 contains plasmepsin, 
pfCRT, and falcipain 2, a chloroquine 
resistance transporter gene.  
 
Further work carried out in the laboratories 
of Dimoupoulos, DeRisi, Kissinger and 
Kafatos has been done to uncover more 
correctly and completely, the functions of 
the predicted genes of Plasmodium 
falciparum at some stages of its life cycle 
instead of considering a whole lot of its 
development stages as Le Roch et al. 
(2003)12 did. Furthermore, the Plasmodium 
parasites suffer large losses during their 
passage through the vector mosquito. The 
mechanisms underlying parasite elimination 
in the mosquito are unknown. Several lines 
of evidence have linked mosquito robust 
immune responses to the documented 
Plasmodium losses without clearly 
indicating the stage specificity and the 
killing mechanisms. Nor have the activation 
of specific immune genes been linked with 
specific elicitors of malaria infected blood. 
The further work listed above also dwelled 
on this challenge. 
 
CONCLUSION AND OPEN PROBLEMS 
Malaria is one of the most serious diseases 
causing 1.5 to 2.7 million deaths every year, 
mostly among children in sub-saharan 
Africa, including Nigeria. The favourable 
climatic changes for the mosquitoes, the 
lack of effective vaccines, the development 
of parasite resistance to drugs and mosquito 
resistance to insecticides contribute to the 
expansion of the disease, and have created 
an acute need for the development of 
additional control strategies.  None of the 
popular laboratories working on microarray 
experiment application to malaria treatment 
is located in Nigeria. Some are even located 
in WHO (World Health Organization) 
certified malaria free countries.  
 
In this paper, in an attempt to develop an 
optimal oligos selection algorithm, we 
 6 
analyzed existing methods used today in 
customized oligo design. In the course of 
doing this, we discovered that the set of 
oligos designed by each algorithm for the 
same gene sequences are at variance and 
OligoArray2.017 will not work on gene 
PFA0135w of chromosome 1 of the genome 
of P. falciparum.  We also uncovered the 
following dry and wet laboratory open 
problems, namely: (i) development of better 
statistical analysis methods for gene 
expression18, (ii) the design of better 
computational methods to derive the genes 
network from gene expression data3, (iii) 
develop further dry/wet laboratory tools to 
streamdown / validate thousands of proteins 
identified in the P. falciparum genome as 
new drugs or vaccine targets. and (iv) Le 
Roch et al.12 noted that the genome 
sequence on their array were derived from 
an isolated, 3D7, that has been maintained in 
culture for generations, and the RNA 
samples were also derived from parasites 
that had been maintained in continuous 
culture for generations; therefore the 
obtained expression patterns may not reflect 
those that exist in parasites replicating 
human hosts. Obtaining the sequence of a 
wild P. falciparum isolate and obtaining 
expression profiles of parasites isolated 
directly from humans will improve the 
biological relevance of the studies. This is 
an open problem for the Nigerian 
experimental biologists. 
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